pyridinoline has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersen, K; Birkebaek, NH; Esberg, G; Hassager, C; Wolthers, O | 1 |
| Barnes, PJ; Fujita, K; Hashimoto, J; Kasayama, S; Miyatake, A; Morimoto, Y; Nagasaka, Y; Nakano, N | 1 |
1 trial(s) available for pyridinoline and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate.
Topics: Administration, Inhalation; Administration, Topical; Amino Acids; Anti-Asthmatic Agents; Anti-Inflammatory Agents; Asthma; Beclomethasone; Bone and Bones; Budesonide; Child; Collagen; Cross-Over Studies; Female; Glucocorticoids; Humans; Male; Osteocalcin; Peptide Fragments; Powders; Pregnenediones; Procollagen | 1995 |
1 other study(ies) available for pyridinoline and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one
| Article | Year |
|---|---|
Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women.
Topics: Absorptiometry, Photon; Administration, Inhalation; Adult; Amino Acids; Anti-Asthmatic Agents; Asthma; Beclomethasone; Biomarkers; Bone Density; Bone Resorption; Disease Susceptibility; Female; Gonadal Steroid Hormones; Humans; Lumbar Vertebrae; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Postmenopause; Premenopause | 2001 |